Literature DB >> 14711994

Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line.

Toru Kondo1, Takao Setoguchi, Tetsuya Taga.   

Abstract

Both stem cells and cancer cells are thought to be capable of unlimited proliferation. Paradoxically, however, some cancers seem to contain stem-like cells (cancer stem cells). To help resolve this paradox, we investigated whether established malignant cell lines, which have been maintained for years in culture, contain a subpopulation of stem cells. In this article, we show that many cancer cell lines contain a small side population (SP), which, in many normal tissues, is thought to contain the stem cells of the tissue. We demonstrate that in the absence of serum the combination of basic fibroblast growth factor and platelet-derived growth factor maintains SP cells in the C6 glioma cell line. Moreover, we show that C6 SP cells, but not non-SP cells, can generate both SP and non-SP cells in culture and are largely responsible for the in vivo malignancy of this cell line. Finally, we provide evidence that C6 SP cells can produce both neurons and glial cells in vitro and in vivo. We propose that many cancer cell lines contain a minor subpopulation of stem cells that is enriched in an SP, can be maintained indefinitely in culture, and is crucial for their malignancy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14711994      PMCID: PMC321758          DOI: 10.1073/pnas.0307618100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

Review 1.  Multidrug resistance in cancer: role of ATP-dependent transporters.

Authors:  Michael M Gottesman; Tito Fojo; Susan E Bates
Journal:  Nat Rev Cancer       Date:  2002-01       Impact factor: 60.716

2.  THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS.

Authors:  L HAYFLICK
Journal:  Exp Cell Res       Date:  1965-03       Impact factor: 3.905

3.  Characterization of neurosphere cell phenotypes by flow cytometry.

Authors:  R Hulspas; P J Quesenberry
Journal:  Cytometry       Date:  2000-07-01

Review 4.  Stem cells, cancer, and cancer stem cells.

Authors:  T Reya; S J Morrison; M F Clarke; I L Weissman
Journal:  Nature       Date:  2001-11-01       Impact factor: 49.962

Review 5.  Platelet-derived growth factor receptors: a therapeutic target in solid tumors.

Authors:  D George
Journal:  Semin Oncol       Date:  2001-10       Impact factor: 4.929

Review 6.  Progenitor cells and glioma formation.

Authors:  E C Holland
Journal:  Curr Opin Neurol       Date:  2001-12       Impact factor: 5.710

Review 7.  ABC transporters as phenotypic markers and functional regulators of stem cells.

Authors:  Kevin D Bunting
Journal:  Stem Cells       Date:  2002       Impact factor: 6.277

8.  A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia.

Authors:  G G Wulf; R Y Wang; I Kuehnle; D Weidner; F Marini; M K Brenner; M Andreeff; M A Goodell
Journal:  Blood       Date:  2001-08-15       Impact factor: 22.113

9.  PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo.

Authors:  C Dai; J C Celestino; Y Okada; D N Louis; G N Fuller; E C Holland
Journal:  Genes Dev       Date:  2001-08-01       Impact factor: 11.361

10.  The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype.

Authors:  S Zhou; J D Schuetz; K D Bunting; A M Colapietro; J Sampath; J J Morris; I Lagutina; G C Grosveld; M Osawa; H Nakauchi; B P Sorrentino
Journal:  Nat Med       Date:  2001-09       Impact factor: 53.440

View more
  330 in total

Review 1.  The biology of head and neck cancer stem cells.

Authors:  Zhaocheng Zhang; Manoel Sant'Ana Filho; Jacques E Nör
Journal:  Oral Oncol       Date:  2011-11-08       Impact factor: 5.337

2.  Evidence for label-retaining tumour-initiating cells in human glioblastoma.

Authors:  Loic P Deleyrolle; Angus Harding; Kathleen Cato; Florian A Siebzehnrubl; Maryam Rahman; Hassan Azari; Sarah Olson; Brian Gabrielli; Geoffrey Osborne; Angelo Vescovi; Brent A Reynolds
Journal:  Brain       Date:  2011-04-22       Impact factor: 13.501

3.  Cancer cells cyclically lose and regain drug-resistant highly tumorigenic features characteristic of a cancer stem-like phenotype.

Authors:  Kaijie He; Tong Xu; Amir Goldkorn
Journal:  Mol Cancer Ther       Date:  2011-04-25       Impact factor: 6.261

4.  Chlorotoxin labeled magnetic nanovectors for targeted gene delivery to glioma.

Authors:  Forrest M Kievit; Omid Veiseh; Chen Fang; Narayan Bhattarai; Donghoon Lee; Richard G Ellenbogen; Miqin Zhang
Journal:  ACS Nano       Date:  2010-08-24       Impact factor: 15.881

5.  Emerging strategies for the identification and targeting of cancer stem cells.

Authors:  Jun Dou; Ning Gu
Journal:  Tumour Biol       Date:  2010-03-25

Review 6.  Involvement of non-vascular stem cells in blood vessel formation.

Authors:  Nobuyuki Takakura
Journal:  Int J Hematol       Date:  2012-02-04       Impact factor: 2.490

7.  Cancer stem cells are enriched in the side population cells in a mouse model of glioma.

Authors:  Molly A Harris; Hyuna Yang; Benjamin E Low; Joydeep Mukherjee; Joydeep Mukherje; Abhijit Guha; Roderick T Bronson; Leonard D Shultz; Mark A Israel; Kyuson Yun
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

8.  Isolation of side population cells from endometrial cancer cells using a violet laser diode.

Authors:  Satoshi Tomiyasu; Tomoyuki Miyamoto; Michihiro Mori; Takahiro Yaguchi; Hiromasa Yakushiji; Setsuyo Ohno; Yasuyuki Miyake; Takuya Sakaguchi; Masatsugu Ueda; Eiji Ohno
Journal:  Hum Cell       Date:  2013-10-04       Impact factor: 4.174

9.  Endometrial cancer side-population cells show prominent migration and have a potential to differentiate into the mesenchymal cell lineage.

Authors:  Kiyoko Kato; Tomoka Takao; Ayumi Kuboyama; Yoshihiro Tanaka; Tatsuhiro Ohgami; Shinichiro Yamaguchi; Sawako Adachi; Tomoko Yoneda; Yousuke Ueoka; Keiji Kato; Shinichi Hayashi; Kazuo Asanoma; Norio Wake
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

10.  Hyaluronan regulates ceruloplasmin production by gliomas and their treatment-resistant multipotent progenitors.

Authors:  Sandra L Tye; Anne G Gilg; Lauren B Tolliver; William G Wheeler; Bryan P Toole; Bernard L Maria
Journal:  J Child Neurol       Date:  2008-10       Impact factor: 1.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.